Tang H - Search Results

1

Estrogen upregulates the IGF-1 signaling pathway in lung cancer through estrogen receptor-β.

Tang H, Liao Y, Chen G, Xu L, Zhang C, Ju S, Zhou S. Tang H, et al. Med Oncol. 2012 Dec;29(4):2640-8. doi: 10.1007/s12032-012-0198-8. Epub 2012 Mar 17. Med Oncol. 2012. PMID: 22427208

2

[Gender-associated differences of lung cancer and mechanism].

Xing X, Liao Y, Tang H, Chen G, Ju S, You L. Xing X, et al. Among authors: tang h. Zhongguo Fei Ai Za Zhi. 2011 Jul;14(7):625-30. doi: 10.3779/j.issn.1009-3419.2011.07.12. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21762635 Free PMC article. Review. Chinese.

3

[Advances of targeted therapy based on estrogen receptor signaling pathway in lung cancer].

Xu L, Liao Y, Tang H, Zhang C, Liu Z. Xu L, et al. Among authors: tang h. Zhongguo Fei Ai Za Zhi. 2011 Sep;14(9):727-32. doi: 10.3779/j.issn.1009-3419.2011.09.07. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21924040 Free PMC article. Review. Chinese.

4

The expression of estrogen receptors β2, 5 identifies and is associated with prognosis in non-small cell lung cancer.

Liu Z, Liao Y, Tang H, Chen G. Liu Z, et al. Among authors: tang h. Endocrine. 2013 Oct;44(2):517-24. doi: 10.1007/s12020-013-9916-z. Epub 2013 Mar 10. Endocrine. 2013. PMID: 23475473

5

Association of preoperative serum IGF- I concentration with clinicopathological parameters in patients with non-small cell lung cancer.

Fu SL, Tang HX, Liao YD, Jiang WY, Xu QZ, Deng Y, Fu XN. Fu SL, et al. J Huazhong Univ Sci Technolog Med Sci. 2013 Apr;33(2):224-227. doi: 10.1007/s11596-013-1101-3. Epub 2013 Apr 17. J Huazhong Univ Sci Technolog Med Sci. 2013. PMID: 23592134

6

Estrogen and insulin-like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice.

Tang H, Liao Y, Xu L, Zhang C, Liu Z, Deng Y, Jiang Z, Fu S, Chen Z, Zhou S. Tang H, et al. Int J Cancer. 2013 Nov 15;133(10):2473-82. doi: 10.1002/ijc.28262. Epub 2013 Jun 12. Int J Cancer. 2013. PMID: 23649836

7

Crosstalk between IGF-1R and other tumor promoting pathways.

Liu C, Zhang Z, Tang H, Jiang Z, You L, Liao Y. Liu C, et al. Among authors: tang h. Curr Pharm Des. 2014;20(17):2912-21. doi: 10.2174/13816128113199990596. Curr Pharm Des. 2014. PMID: 23944361 Review.

8

Advances in targeting insulin-like growth factor signaling pathway in cancer treatment.

You L, Liu C, Tang H, Liao Y, Fu S. You L, et al. Among authors: tang h. Curr Pharm Des. 2014;20(17):2899-911. doi: 10.2174/13816128113199990595. Curr Pharm Des. 2014. PMID: 23944362 Review.

9

Fulvestrant-mediated inhibition of estrogen receptor signaling slows lung cancer progression.

Tang H, Liao Y, Zhang C, Chen G, Xu L, Liu Z, Fu S, Yu L, Zhou S. Tang H, et al. Oncol Res. 2014;22(1):13-20. doi: 10.3727/096504014X14077751730315. Oncol Res. 2014. PMID: 25700354 Free PMC article.

10

G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.

Liu C, Liao Y, Fan S, Tang H, Jiang Z, Zhou B, Xiong J, Zhou S, Zou M, Wang J. Liu C, et al. Among authors: tang h. Med Oncol. 2015 Apr;32(4):104. doi: 10.1007/s12032-015-0558-2. Epub 2015 Mar 6. Med Oncol. 2015. PMID: 25744245

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,853 results

Search Page

Filters